HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shinsaku Imashuku Selected Research

Juvenile Xanthogranuloma

1/2020[Successful unrelated cord blood transplantation for extensive meningeal juvenile xanthogranuloma developing after treatment of Langerhans cell histiocytosis in a child].
6/2004Successful treatment of congenital systemic juvenile xanthogranuloma with Langerhans cell histiocytosis-based chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shinsaku Imashuku Research Topics

Disease

24Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
01/2021 - 08/2003
13Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
09/2013 - 02/2002
10Neoplasms (Cancer)
10/2021 - 07/2004
9Leukemia
12/2018 - 02/2002
9Infections
01/2018 - 07/2004
7Hemorrhage
03/2021 - 01/2012
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2018 - 02/2002
6Hemolytic Anemia
01/2022 - 09/2003
6Central Nervous System Diseases (CNS Diseases)
10/2015 - 06/2002
6Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
07/2004 - 06/2002
5Lymphoma (Lymphomas)
01/2016 - 03/2003
4Anemia
04/2018 - 05/2005
4Autoimmune Diseases (Autoimmune Disease)
12/2015 - 01/2011
3Thrombosis (Thrombus)
04/2021 - 01/2019
3Sepsis (Septicemia)
04/2021 - 07/2004
3Fever (Fevers)
01/2016 - 03/2005
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2015 - 11/2009
3Chromosome Aberrations (Chromosome Abnormalities)
11/2003 - 04/2003
2Hyperhomocysteinemia
01/2021 - 06/2020
2Thromboembolism
01/2021 - 06/2020
2Juvenile Xanthogranuloma
01/2020 - 06/2004
2Neurogenic Diabetes Insipidus (Central Diabetes Insipidus)
01/2019 - 12/2011
2Pathologic Complete Response
12/2018 - 06/2005
2Juvenile Myelomonocytic Leukemia
12/2018 - 08/2004
2Hyperbilirubinemia
04/2018 - 01/2018
2Hemochromatosis (Bronze Diabetes)
02/2018 - 07/2016
2Diabetes Mellitus
02/2018 - 07/2016
2Hemolysis
01/2018 - 06/2016
2Septic Shock (Toxic Shock Syndrome)
01/2018 - 04/2011
2Diabetes Insipidus
01/2018 - 11/2004
2Pneumonia (Pneumonitis)
01/2017 - 09/2002
2Hemophilia A (Haemophilia)
12/2015 - 01/2012
2Thrombocytopenia (Thrombopenia)
10/2015 - 10/2005
2Inflammation (Inflammations)
02/2015 - 01/2015
2Hematologic Diseases (Blood Diseases)
01/2015 - 11/2007
2Hearing Loss (Hearing Impairment)
11/2007 - 07/2004
2Neutropenia
01/2006 - 11/2003
2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
10/2005 - 08/2003
2GATA2 Deficiency
06/2005 - 11/2003
2Aplastic Anemia (Anemia, Hypoplastic)
06/2005 - 11/2003
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2004 - 08/2003
1Iron-Refractory Iron Deficiency Anemia
01/2022
1Iron Deficiencies
01/2022
1Virus Diseases (Viral Diseases)
10/2021
1Afibrinogenemia (Fibrinogen Deficiency)
03/2021
1Uterine Hemorrhage (Uterine Bleeding)
03/2021
1Lung Diseases (Lung Disease)
01/2021
1Alcoholism (Alcohol Abuse)
01/2021
1Polycythemia (Erythrocytosis)
06/2020
1Pulmonary Embolism
06/2020
1Venous Thromboembolism
06/2020

Drug/Important Bio-Agent (IBA)

8Prednisolone (Predate)FDA LinkGeneric
01/2020 - 05/2005
7Intravenous Immunoglobulins (IVIG)FDA Link
10/2021 - 10/2005
6PerforinIBA
11/2007 - 01/2005
5Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2021 - 03/2005
5Etoposide (VP 16)FDA LinkGeneric
10/2021 - 02/2002
4CytokinesIBA
01/2017 - 01/2006
4Rituximab (Mabthera)FDA Link
09/2013 - 05/2005
4Proteins (Proteins, Gene)FDA Link
09/2009 - 02/2002
3HomocysteineIBA
01/2021 - 04/2018
3Interleukin-1 (Interleukin 1)IBA
01/2018 - 01/2015
3Immunosuppressive Agents (Immunosuppressants)IBA
04/2011 - 11/2003
3Protein Isoforms (Isoforms)IBA
05/2008 - 02/2002
3Imatinib Mesylate (Gleevec)FDA Link
05/2005 - 08/2003
2Protein CIBA
04/2021 - 01/2020
2recombinant FVIIa (rFVIIa)FDA Link
03/2021 - 01/2012
2Mitogen-Activated Protein KinasesIBA
01/2021 - 10/2020
2Folic Acid (Vitamin M)FDA LinkGeneric
01/2021 - 06/2020
2Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
06/2020 - 04/2018
2Factor V (Coagulation Factor V)IBA
10/2019 - 01/2011
2Cytarabine (Cytosar-U)FDA LinkGeneric
01/2019 - 07/2016
2Intrinsic FactorFDA Link
04/2018 - 01/2015
2AntibodiesIBA
04/2018 - 01/2015
2ChemokinesIBA
01/2017 - 12/2014
2Pharmaceutical PreparationsIBA
12/2015 - 10/2008
2Immunoglobulins (Immunoglobulin)IBA
10/2015 - 11/2009
2Biomarkers (Surrogate Marker)IBA
10/2015 - 08/2006
2Immunoglobulin G (IgG)IBA
01/2013 - 09/2009
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
06/2005 - 11/2003
2Tacrolimus (Prograf)FDA LinkGeneric
03/2005 - 11/2003
2EnzymesIBA
03/2005 - 09/2003
2Melphalan (Alkeran)FDA LinkGeneric
11/2003 - 03/2003
1HemosiderinIBA
01/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
10/2021
1Monoclonal AntibodiesIBA
10/2021
1EmapalumabIBA
10/2021
1Factor VIIa (Activated Factor VII)IBA
03/2021
1Fibrinogen (Factor I)FDA Link
03/2021
1Hemoglobins (Hemoglobin)IBA
06/2020
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
06/2020

Therapy/Procedure

18Therapeutics
08/2018 - 02/2002
13Drug Therapy (Chemotherapy)
12/2018 - 09/2003
8Hematopoietic Stem Cell Transplantation
10/2021 - 06/2002
8Bone Marrow Transplantation (Transplantation, Bone Marrow)
10/2005 - 09/2002
7Aftercare (After-Treatment)
01/2020 - 04/2003
5Transplantation
01/2020 - 09/2002
2Renal Dialysis (Hemodialysis)
10/2019 - 01/2018
2Tooth Extraction (Tooth Extractions)
01/2018 - 12/2015
2Stem Cell Transplantation
01/2016 - 05/2004
2Splenectomy
06/2012 - 12/2004